Evidence map›Paper›PMID 27597974›Full record

ArticleBioMed research international2016

High Dimensional Variable Selection with Error Control.

Sangjin Kim, Susan Halabi

Abstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Sparse-Input Neural Network using Group Concave Regularization.Transactions on machine learning research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sangjin KimDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Box 2717, Durham, NC 27710, USA.ORCID 0000-0002-2496-7211
Susan HalabiDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Box 2717, Durham, NC 27710, USA.ORCID 0000-0003-4135-2777

Funding

Validation of prognostic and pathway signatures in lethal prostate cancerU01CA157703 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLEAVE, MARTIN EDWIN, HALABI, SUSAN · 2011 to 2015
$2.5M
Prognostic Models of Clinical Outcomes In Men With Castration Resistant ProstateR01CA155296 · NCI · DUKE UNIVERSITY · PI HALABI, SUSAN · 2011 to 2014
$914k
NCI NIH HHS R01 CA155296NCI NIH HHS U01 CA157703
6 · The paper itself

Abstract

Background. The iterative sure independence screening (ISIS) is a popular method in selecting important variables while maintaining most of the informative variables relevant to the outcome in high throughput data. However, it not only is computationally intensive but also may cause high false discovery rate (FDR). We propose to use the FDR as a screening method to reduce the high dimension to a lower dimension as well as controlling the FDR with three popular variable selection methods: LASSO, SCAD, and MCP. Method. The three methods with the proposed screenings were applied to prostate cancer data with presence of metastasis as the outcome. Results. Simulations showed that the three variable selection methods with the proposed screenings controlled the predefined FDR and produced high area under the receiver operating characteristic curve (AUROC) scores. In applying these methods to the prostate cancer example, LASSO and MCP selected 12 and 8 genes and produced AUROC scores of 0.746 and 0.764, respectively. Conclusions. We demonstrated that the variable selection methods with the sequential use of FDR and ISIS not only controlled the predefined FDR in the final models but also had relatively high AUROC scores.

Indexed as

Data Interpretation, StatisticalResearch DesignArea Under CurveComputer SimulationFalse Positive ReactionsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleNeoplasm MetastasisProstatic NeoplasmsRegression AnalysisReproducibility of ResultsROC CurveSensitivity and Specificity

Identifiers

PMID27597974
PMCPMC5002494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.